• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of Montreal

Headquarters: Montreal, QC, Canada
Website: http://www.umontreal.ca
Year Founded: 1878
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Feb 27, 2025
Discovery & Translation

Science Spotlight: Clues from the clinic for neoantigen prioritization

BioCentury’s roundup of translational innovations also includes causal biology for a heart condition, and the biological foundational model Evo 2
Read More
BioCentury | Dec 7, 2022
Distillery Therapeutics

Non-opioid, non-sedating analgesic targeting ADRA2A

Read More
BioCentury | Nov 8, 2022
Distillery Therapeutics

DISC1 for vision loss in glaucoma

Read More
BioCentury | Mar 4, 2022
Distillery Therapeutics

An Fc-enhanced, non-neutralizing mAb for COVID-19 prophylaxis

Read More
BioCentury | Dec 3, 2021
Distillery Therapeutics

RvD2 for Duchenne muscular dystrophy

Read More
BioCentury | Aug 27, 2021
Distillery Therapeutics

Improving cardiac cell therapy for MI with KCNN4 overexpression

Read More
BioCentury | May 1, 2020
Distillery Therapeutics

The lipids LXA4 and RvD1 as treatment for E. coli pneumonia

Read More
BioCentury | Jul 26, 2019
Translation in Brief

GI infection as Parkinson’s trigger

McGill, UMontreal team describe chain of events leading from GI infection to Parkinson’s disease
Read More
BioCentury | Jul 11, 2019
Translation in Brief

PARP inhibitors plus senolytics: a double hit on cancer

A new synthetic lethality approach combines PARP inhibitors with senolytic compounds to boost cancer killing
Read More
BioCentury | Dec 14, 2018
Emerging Company Profile

ExCellThera’s safer allogeneic transplants

How ExCellThera is increasing the safety of allogeneic stem cell transplants
Read More
Items per page:
1 - 10 of 70